News in Brief

Visible particulates in drug vials spark US FDA recall

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Nordroden)
(Image: Getty/Nordroden)
The US FDA has issued a recall of non-expired products marketed as sterile made by Coastal Meds after an investigation of the outsourcing facility found poor sterile production practices.

The US Food and Drug Administration (FDA) has issued a recall of all non-expired products marketed as sterile made by Coastal Meds LLC, a 503B registered outsourcing facility in Biloxi, Mississippi.

The FDA inspected Coastal Meds at which time it observed “visible particulates and poor sterile production practices, which further raise concerns about particulates in Coastal Meds’ drug products intended for injection,”​ the administration said in the release.

Coastal Meds initiated a voluntarily recall of all products intended to be sterile on April 5, 2018, but has since failed to inform the public.

The FDA is not aware of any adverse event reports associated with the drug products.

Related topics: Drug Delivery, Regulations

Related news

Show more

Related product

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

PatSnap | 15-Jun-2022 | Technical / White Paper

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....

Follow us

Products

View more

Webinars